Translate this page into:
A rare case of deformity: Fibrodysplasia ossificans progressiva
*Corresponding author: Vykuntaraju K. Gowda, Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India. drknvraju08@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Gowda VK, Rangaiah S, Srinivasan VM, Narayana Vamyanmane DK. A rare case of deformity: Fibrodysplasia ossificans progressiva. Karnataka Paediatr J 2022;37:86-9.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder and the most debilitating condition of heterotopic ossification in humans. Misdiagnosis is common and they suffer from complications of incorrect diagnosis and subsequent inappropriate treatment hence, to create awareness, we are reporting a genetically confirmed case of FOP. A 10-year-old boy, born to a non-consanguineously married couple, presented with progressive stiffness of the neck, back, and limbs with restriction of movements. Examination showed two firm non-tender immobile swellings over the back with scoliosis towards the left side. A bilateral hallux valgus deformity with restricted movements of the great toe was noted. Outside treated as mixed connective tissue disorder without any improvement. The X-ray showed calcifications in the swellings. Genetic testing showed the pathogenic variant in the activin A receptor type 1 gene. The FOP should be considered in children presenting with progressive stiffness, deformity of the feet, and ectopic ossifications to avoid misdiagnosis and inappropriate treatment.
Keywords
Activin A receptor type 1 gene
Bilateral hallux valgus
Fibrodysplasia ossificans progressive
INTRODUCTION
Fibrodysplasia ossificans progressiva (FOP) is an autosomal dominantly inherited disorder of connective tissues characterised by progressive heterotopic (extra-skeletal) calcification. In the eighteenth century, it was called by the name myositis ossificans progressiva by von Dusch in 1868. Since the muscles were only secondarily affected, the term fibrodysplasia was coined by Bauer and Bode in 1940. It is caused by fibroproliferative lesions in tendons, ligaments, and skeletal muscles.[1] Activating mutations in the activin A receptor type 1 (ACVR1) gene are responsible for causing this disease.[2] FOP is a very rare disorder with a prevalence of approximately one case in 2 million individuals worldwide.[3] Most of the FOP cases are misdiagnosed as having osteosarcoma, pseudohypoparathyroidism, or hypervitaminosis D before heterotopic ossifications.[4] Hence, we are reporting this case.
CASE REPORT
A 10-year-old male child, born to a non-consanguineously married couple with a normal perinatal history, presented with progressive stiffness of the neck, limbs, and back with restriction of movements noticed for the 5th month of life. At 5 months of age, the mother noticed swelling in the back of the neck which was initially soft but subsequently become hard. The later child gradually developed similar swellings over the nape of the neck, back, shoulder and lower limbs. The swellings were painless and immobile. It was associated with bending of the spine towards the right side, which became prominent at 3 years of age. The child also started developing stiffness and restricted movements of the left upper limb predominantly at the elbow joint. Initially, finger movements were normal, later, the fine movements of both hands were involved. Starting from 8 years of age, the child developed difficulty in opening the mouth and later progressed to difficulty in talking. Child development was normal in all the domains, but his motor activities were limited due to stiffness.
On examination, the weight of 14 kg (<3rd centile) and height of 137 cm (25th–50th centile), epicanthal folds, low set ears, restricted mouth opening (Mallampati grade III), short neck, barrel-shaped chest with widely spaced nipples, scoliosis and two firm non-tender immobile swellings over the back with scoliosis towards the left side [Figures 1a and b] and left gunstock deformity with greatly reduced range of movements. Bilateral hallux valgus present [Figure 1c] with restricted movements of the great toe was noted. Systemic examination was normal. Routine investigations such as complete blood counts, erythrocyte sedimentation rate, C-reactive protein, anti-streptolysin O, and anti-nuclear antibodies were normal. The serum creatine kinase levels were normal. The X-ray showed scoliosis with convexity towards the left, partial fusion of upper lumbar vertebral bodies on the right side with extensive ossifications in adjacent soft tissues, ossification of the interspinous ligament with a fusion of the cervical spinous processes, osteopenia in tarsal, metatarsal and phalanges and hallux valgus deformity in the left leg [Figure 2]. Based on the above clinical and radiological features, we suspected FOP. Targeted next-generation sequencing showed pathogenic variant c.617 G >A; P.R206H allele mutation in exon 6 of the ACVR1 gene, hence confirming our diagnosis of FOP.
DISCUSSION
FOP is a rare debilitating connective tissue disorder characterised by a deformity of the great toes from infancy and postnatal heterotopic ossification.[5] Congenital malformation of the great toes (98%) is the characteristic diagnostic feature of the disease, which is usually associated with episodes of soft-tissue swelling (flare-ups) which can spontaneously regress or turn into heterotopic bone. Formations of this heterotopic bone over joints lead to ankylosis and progressive immobility.[6]
Here, we describe an Indian boy with multiple painless, swellings over the body with restriction of movements at various joints. We diagnosed him as FOP based on the stiffness of limbs, deformity of the feet and ectopic ossifications and confirmed by the pathogenic variant in the ACVR1 gene on next-generation sequencing. It has been reported that a biopsy of the lesion in these patients results in clinical deterioration and should be avoided.[6] Hence, we did not do the biopsy, and also, the biopsy will not differentiate FOP from other causes of heterotopic ossifications.
The pathogenesis of FOP is dysregulated bone morphogenetic protein (BMP) signaling. Classic FOP is caused by a single common heterozygous mutation (617G>A; R206H) identified in the cytoplasmic domain of ACVR1/activin-like kinase 2, a BMP type I receptor, in five small multigenerational families and all sporadically affected individuals.[2] Evidence suggests that the involvement of the inflammatory component of the immune system plays a critical role in FOP.[7] The presence of macrophages, lymphocytes, and mast cells in the early FOP lesions, macrophage and lymphocyte-associated death of skeletal muscle, flare-ups following viral infections, the intermittent timing of flare-ups and the beneficial response of the early flare-ups to corticosteroids support the involvement of the innate immune system in the manifestations of FOP.[8]
Madhuri et al.[5] reported a series of 14 patients with the FOP in which 12 patients had P. Arg206His. Most of these cases had bilateral hallux valgus and major heterotopic calcification in the thoracolumbar spine, shoulder and hip joints. Similar findings were noted in our case in the form of hallux valgus, metatarsophalangeal joint of the great toe and heterotopic calcification in the spine, neck, shoulder, elbow and hip region.
FOP is commonly misdiagnosed as aggressive juvenile fibromatosis, mixed connective tissue disorder (MCTD), lymphedema or soft-tissue sarcoma.[9] We considered the possibilities of bone tumours, congenital muscular dystrophy, arthrogryposis multiplex congenital, scleroderma and MCTD. We ruled out neuromuscular problems as the child had normal power and preserved deep tendon reflexes. MCTD and scleroderma were also unlikely as there was no fever, arthritis and normal inflammatory markers.
A heterozygous missense variation in exon 6 of the ACVR1 gene (chr2: g.158630626C>T) that results in the amino acid substitution of Histidine for Arginine at codon 206 (P. Arg206His) was noted. The observed variation lies in the transforming growth factor-beta type I GS-motif domain of the ACVR1 protein and was previously reported.[5]
The median lifespan is approximately 40 years of age. Most patients are wheelchair-bound by the end of the second decade of life and commonly die of complications of thoracic insufficiency syndrome.[10] We managed the child conservatively with symptomatic treatment. We advised avoiding intramuscular injections, changing intramuscular injections to subcutaneous routes whenever possible and aggressive management of febrile illnesses. Genetic testing of the ACVR1gene should be considered rather than biopsy to confirm the diagnosis as a biopsy can cause new lesions.
CONCLUSION
The FOP should be considered in children presenting with progressive stiffness, deformity of the feet and ectopic ossifications to avoid misdiagnosis and inappropriate treatment.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflicts of interest.
Financial support and sponsorship
Nil.
References
- Erbpathologie der stutzgewebebeim menschen In: Bauer KH, Bode W, eds. Erbpathologie Korperliche Zustande and Funktionen. Vol 1. Berlin: Springer Verlag; 1940. p. :105. Quoted by McKusick (1972)
- [Google Scholar]
- A recurrent mutation in the BMP Type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525-7.
- [CrossRef] [PubMed] [Google Scholar]
- The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab. 2005;3:201-4.
- [CrossRef] [Google Scholar]
- An unusual case of rapidly progressive contractures: Case report and brief review. Ann Indian Acad Neurol. 2008;11:119-22.
- [CrossRef] [PubMed] [Google Scholar]
- Classical and atypical fibrodysplasia ossificans progressiva in India. Ann Hum Genet. 2015;79:245-52.
- [CrossRef] [PubMed] [Google Scholar]
- Fibrodysplasia ossificans progressiva: Report of a case and review of articles. Iran J Radiol. 2011;8:113-7.
- [Google Scholar]
- Morphogen receptor genes and metamorphogenes: Skeleton keys to metamorphosis. Ann N Y Acad Sci. 2007;1116:113-33.
- [CrossRef] [PubMed] [Google Scholar]
- Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway. Clin Rev Bone Miner Metab. 2005;3:189-93.
- [CrossRef] [Google Scholar]
- Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005;116:e654-61.
- [CrossRef] [PubMed] [Google Scholar]
- Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am. 2010;92:686-91.
- [CrossRef] [PubMed] [Google Scholar]